CSIMarket Company Name, Ticker, Suppliers, else..
 
Prf Technologies Ltd   (NASDAQ: PRFX)
 

Prf Technologies Ltd's Suppliers Performance

PRFX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
PRFX Costs vs Sales of Suppliers Growth

• More on PRFX Suppliers






Prf Technologies Ltd's Comment on Supply Chain


The company does not own or operate cGMP manufacturing facilities and relies on contract manufacturers and collaboration partners for production. OcuRing™-K is produced in-house, with Resonetics, LLC responsible for finalization and sterilization. Some critical materials for OcuRing™-K are sourced from single suppliers, which may pose risks of supply interruptions affecting development timelines or costs. For PRF-110, the company engaged Pharmaceutics International Inc, a U.S.-based contract manufacturing organization, following regulatory and GMP compliance issues with a former CMO in Israel. Manufacturing process enhancements were implemented in 2022, addressing product stability issues and enabling the initiation of a Phase 3 trial in March 2023. The Phase 3 trial did not meet its primary endpoint, leading to a reduction in research and development activities for PRF-110.

Prf Technologies Ltd's Comment on Supply Chain


The company does not own or operate cGMP manufacturing facilities and relies on contract manufacturers and collaboration partners for production. OcuRing™-K is produced in-house, with Resonetics, LLC responsible for finalization and sterilization. Some critical materials for OcuRing™-K are sourced from single suppliers, which may pose risks of supply interruptions affecting development timelines or costs. For PRF-110, the company engaged Pharmaceutics International Inc, a U.S.-based contract manufacturing organization, following regulatory and GMP compliance issues with a former CMO in Israel. Manufacturing process enhancements were implemented in 2022, addressing product stability issues and enabling the initiation of a Phase 3 trial in March 2023. The Phase 3 trial did not meet its primary endpoint, leading to a reduction in research and development activities for PRF-110.







PRFX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Prf Technologies Ltd 0.63 0.02 -5.02 7
SUBTOTAL 0.00 0.00 0.00 -


Sources: Prf Technologies Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Prf Technologies Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.